相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dual role of p53 amyloid formation in cancer; loss of function and gain of toxicity
Cristian A. Lasagna-Reeves et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Evidence for novel aspects of Nox4 oxidase regulation of mitochondrial function and peroxide generation in an endothelial cell model of senescence
Michael S. Wolin
BIOCHEMICAL JOURNAL (2013)
Aggregation Prone Regions and Gatekeeping Residues in Protein Sequences
Jacinte Beerten et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
Folding of a Cyclin Box LINKING MULTITARGET BINDING TO MARGINAL STABILITY, OLIGOMERIZATION, AND AGGREGATION OF THE RETINOBLASTOMA TUMOR SUPPRESSOR AB POCKET DOMAIN
Lucia B. Chemes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis
P. Dong et al.
ONCOGENE (2013)
Potential roles for prions and protein-only inheritance in cancer
H. Antony et al.
CANCER AND METASTASIS REVIEWS (2012)
The rebel angel: mutant p53 as the driving oncogene in breast cancer
Dawid Walerych et al.
CARCINOGENESIS (2012)
Transmissible Proteins: Expanding the Prion Heresy
Claudio Soto
CELL (2012)
Mutant p53: one name, many proteins
William A. Freed-Pastor et al.
GENES & DEVELOPMENT (2012)
Mutant p53 Aggregates into Prion-like Amyloid Oligomers and Fibrils IMPLICATIONS FOR CANCER
Ana P. D. Ano Bom et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Molecular Mechanism of Mutant p53 Stabilization: The Role of HSP70 and MDM2
Milena Wiech et al.
PLOS ONE (2012)
An Intrinsically Disordered Region of the Acetyltransferase p300 with Similarity to Prion-Like Domains Plays a Role in Aggregation
Alexander Kirilyuk et al.
PLOS ONE (2012)
First-order rate-determining aggregation mechanism of p53 and its implications
GuoZhen Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Kinetic mechanism of p53 oncogenic mutant aggregation and its inhibition
Rainer Wilcken et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Structural features and cytotoxicity of amyloid oligomers: Implications in Alzheimer's disease and other diseases with amyloid deposits
Massimo Stefani
PROGRESS IN NEUROBIOLOGY (2012)
Atomic View of a Toxic Amyloid Small Oligomer
Arthur Laganowsky et al.
SCIENCE (2012)
A Unifying Role for Prions in Neurodegenerative Diseases
Stanley B. Prusiner
SCIENCE (2012)
The role of RNA in mammalian prion protein conversion
Mariana P. B. Gomes et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2012)
MicroRNAs in the p53 network: micromanagement of tumour suppression
Heiko Hermeking
NATURE REVIEWS CANCER (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Cholesterol Secosterol Aldehydes Induce Amyloidogenesis and Dysfunction of Wild-Type Tumor Protein p53
Jorge Nieva et al.
CHEMISTRY & BIOLOGY (2011)
Co-localization of mutant p53 and amyloid-like protein aggregates in breast tumors
Claudia B. Levy et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)
p53 and its mutants in tumor cell migration and invasion
Patricia A. J. Muller et al.
JOURNAL OF CELL BIOLOGY (2011)
Heparin Binding by Murine Recombinant Prion Protein Leads to Transient Aggregation and Formation of RNA-Resistant Species
Tuane C. R. G. Vieira et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Gain of function of mutant p53 by coaggregation with multiple tumor suppressors
Jie Xu et al.
NATURE CHEMICAL BIOLOGY (2011)
The client protein p53 adopts a molten globule-like state in the presence of Hsp90
Sung Jean Park et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
Single-Molecule characterization of oligomerization kinetics and equilibria of the tumor suppressor p53
Sridharan Rajagopalan et al.
NUCLEIC ACIDS RESEARCH (2011)
Quaternary structure of the specific p53-DNA complex reveals the mechanism of p53 mutant dominance
Ricardo Aramayo et al.
NUCLEIC ACIDS RESEARCH (2011)
Proteasome inhibitors induce nucleolar aggregation of proteasome target proteins and polyadenylated RNA by altering ubiquitin availability
L. Latonen et al.
ONCOGENE (2011)
Intermolecular transmission of superoxide dismutase 1 misfolding in living cells
Leslie I. Grad et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Misfolded protein aggregates: Mechanisms, structures and potential for disease transmission
Ines Moreno-Gonzalez et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2011)
Prion hypothesis: the end of the controversy?
Claudio Soto
TRENDS IN BIOCHEMICAL SCIENCES (2011)
Ligand Binding and Hydration in Protein Misfolding: Insights from Studies of Prion and p53 Tumor Suppressor Proteins
Jerson L. Silva et al.
ACCOUNTS OF CHEMICAL RESEARCH (2010)
PrP interactions with nucleic acids and glycosaminoglycans in function and disease
Jerson L. Silva et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2010)
The p53 Core Domain Is a Molten Globule at Low pH FUNCTIONAL IMPLICATIONS OF A PARTIALLY UNFOLDED STRUCTURE
Ana Paula D. Ano Bom et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Getting a Grip on Prions: Oligomers, Amyloids, and Pathological Membrane Interactions
Byron Caughey et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2009)
Cognate DNA Stabilizes the Tumor Suppressor p53 and Prevents Misfolding and Aggregation
Daniella Ishimaru et al.
BIOCHEMISTRY (2009)
Mutant p53 Drives Invasion by Promoting Integrin Recycling
Patricia A. J. Muller et al.
CELL (2009)
p53 isoforms - A conspiracy to kidnap p53 tumor suppressor activity?
V. Marcel et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
In Vitro Recapitulating of TP53 Mutagenesis in Hepatocellular Carcinoma Associated With Dietary Aflatoxin B1 Exposure
Ahmad Besaratinia et al.
GASTROENTEROLOGY (2009)
30 years and a long way into p53 research
Pierre Hainaut et al.
LANCET ONCOLOGY (2009)
Awakening guardian angels: drugging the p53 pathway
Christopher J. Brown et al.
NATURE REVIEWS CANCER (2009)
A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients
Jan Alsner et al.
ACTA ONCOLOGICA (2008)
Structural biology of the tumor suppressor p53
Andreas C. Joerger et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2008)
The (1-63) region of the p53 transactivation domain aggregates in vitro into cytotoxic amyloid assemblies
Stefania Rigacci et al.
BIOPHYSICAL JOURNAL (2008)
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation
Jia-Yi Li et al.
NATURE MEDICINE (2008)
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype:: Lessons from recent developments in the IARC TP53 database
Audrey Petitjean et al.
HUMAN MUTATION (2007)
p53 in health and disease
Karen H. Vousden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer
M Olivier et al.
CLINICAL CANCER RESEARCH (2006)
Unfolding, aggregation, and amyloid formation by the tetramerization domain from mutant p53 associated with lung cancer
Y Higashimoto et al.
BIOCHEMISTRY (2006)
Locus-specific mutation databases: pitfalls and good practice based on the p53 experience
T Soussi et al.
NATURE REVIEWS CANCER (2006)
p53 isoforms can regulate p53 transcriptional activity
JC Bourdon et al.
GENES & DEVELOPMENT (2005)
Principles of protein folding, misfolding and aggregation
CM Dobson
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2004)
Reversible aggregation plays a crucial role on the folding landscape of p53 core domain
D Ishimaru et al.
BIOPHYSICAL JOURNAL (2004)
Protein aggregation and neurodegenerative disease
CA Ross et al.
NATURE MEDICINE (2004)
Conversion of wild-type p53 core domain into a conformation that mimics a hot-spot mutant
D Ishimaru et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Fibrillar aggregates of the tumor suppressor p53 core domain
D Ishimaru et al.
BIOCHEMISTRY (2003)
Kinetic instability of p53 core domain mutants - Implications for rescue by small molecules
A Friedler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
On the origin of G → T transversions in lung cancer
GP Pfeifer et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2003)
Reversible amyloid formation by the p53 tetramerization domain and a cancer-associated mutant
AS Lee et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Structure, function, and aggregation of the zinc-free form of the p53 DNA binding domain
JS Butler et al.
BIOCHEMISTRY (2003)
Molecular mechanism of the interaction between MDM2 and p53
O Schon et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
TP53 mutations in breast cancer tumors of patients from Rio de Janeiro, Brazil:: Association with risk factors and tumor characteristics
TA Simao et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function
A de Vries et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
DNA converts cellular prion protein into the β-sheet conformation and inhibits prion peptide aggregation
Y Cordeiro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
